Read Health Law updates, alerts, news, and legal analysis from leading lawyers and law firms:
Generic Drugs to Market - What's the Climate in 2014?
What's Next in Health Reform 2014
Health Care Antitrust & the Supreme Court – Interview with Bruce Sokler, Member, Mintz Levin
What Employers Need to Know about Obesity in the Workplace
Next Accreditation System – Interview with Andy Roth, Member, Mintz Levin
Affordable Care Act Delays - What it Really Means for Employers
Innovative Exit Strategies for Life Sciences Companies – Interview with Bill Whelan, Member, Mintz Levin
The Affordable Care Act & the Impact on the C-Suite – Interview with Alden Bianchi, Member, Mintz Levin
The Sunshine Act: Putting It into Practice – Interview with Karen Lovitch, Member, Mintz Levin
The Affordable Care Act: The Structure of Health Plans – Interview with Alden Bianchi, Member, Mintz Levin
Financing Trends in Life Sciences – Interview with Bill Whelan, Member, Mintz Levin
Building Strong Client Relationships – Interview with Andy Urban, Vice Chairman, Mintz Levin
The Transformation of the VC Business Model – Interview with Bill Whelan, Member, Mintz Levin
What Is Driving Stepped Up Government Health Care Enforcement? – Interview with Hope Foster, Member, Mintz Levin
Collaborative Development Financings by Richard Hsu
PODCAST - Inside Law- Hot Topics in Health Care From the President of the American Health Lawyers Association
Clinton: SCOTUS Myriad Genetics Decision 'Terrific'
PODCAST - Inside Law - HIPAA Changes Overview by Emily Wey
Going on the Offense: Proactive Strategies to Reduce Uncertainty
Craft Beer Boom in Michigan
For many years, there has been an assumption that methods of medical treatment are patentable under Australian law, but this has never actually been tested at the highest judicial level.
For-profits and nonprofits in life sciences team up -
Nonprofit groups are actively supporting research to solve tough medical challenges. Life sciences and pharma companies are eager to accelerate product development....more
..Increase in penalties for non-compliance
-On 12 March 2014 substantial amendments to the Privacy Act come into effect. The new laws are backed by a significant increase in penalties for...more
Last month, the Illinois Department of Natural Resources (“IDNR”) published its first draft of the regulations (62 Ill. Adm. Code 245) (the “HFRA Draft Regulations”) under the Illinois Hydraulic Fracturing Regulatory Act (225...more
What is the climate for getting generic drugs to market in 2014 and what are the obstacles? Polsinelli Shareholder Gary Hood leads the firm's pharmaceutical/Hatch-Waxman patent litigation practice. He has experience in a...more
The High Court of Australia yesterday issued its long awaited decision in a dispute between Apotex Pty Ltd (Apotex) and Sanofi-Aventis Australia Pty Ltd and related entities (collectively, Sanofi) concerning Sanofi's...more
ON 4 DECEMBER 2013, THE HIGH COURT JUDGMENT IN APOTEX PTY LTD V SANOFI-AVENTIS AUSTRALIA PTY LTD & ORS  HCA 50 WAS DELIVERED. THIS IS THE FIRST OCCASION THAT THE HIGH COURT HAS CONSIDERED WHETHER METHODS OF MEDICAL...more
Medical devices are becoming more and more important.
Like pharmaceutical products, they are positioned at the intersection of crucial interests.
Some of these interests are traditionally dealt with by IP...more
Last week, the National Institutes of Health denied a petition from a coalition of "public interest" groups who petitioned the agency to exercise so-called "march-in rights" under provisions of the Bayh-Dole Act against...more
In This Article:
Federal Government; Alberta; British Columbia; Manitoba; New Brunswick; Newfoundland; Northwest Territories; Nova Scotia; Nunavut; Ontario; Prince Edward Island; Québec/Quebec; Saskatchewan; and...more
In this issue:
- How to Expedite Examination of a Patent Application
- The FDA Releases Final Guidance for Mobile Medical Applications
- Creating Value in the Medtech Industry Using a Gender Lens
Full Federal Court considers new patent entitlement laws -
Reckitt Benckiser Healthcare (UK) Ltd v GlaxoSmithKline Australia Pty Ltd  FCA 583 -
The Full Federal Court has overturned Justice Rares' decision...more
In a perspective published in the August 29 issue of the New England Journal of Medicine, Dr. Howard Markel outlines the events leading up to the enactment of the Bayh-Dole Act and states that "a review of [the Act's] origins...more
Attorney Bill Whelan, Co-chair of Mintz Levin's Life Sciences Practice, discusses what is driving financing trends in the life sciences....more
Actress Angelina Jolie recently spent around $3200 to take one of Myriad Genetics’ many breast cancer screening tests. When the test revealed that a mutation existed somewhere in a sequence of 81,000 nucleotides found on her...more
Last month, in a letter to the U.S. Trade Representative, Ambassador Michael Froman, Biotechnology Industry Organization (BIO) President and CEO James Greenwood expressed support for the efforts of the Obama Administration to...more
Developing countries face significant medical challenges. ...more
Medicine is evolving from a global, one-size-fits-all approach to a more individualized approach that tailors treatment specifically for each patient.
Originally published in The Journal Record - August 8, 2013....more
Breast Cancer – Patents
Introduction: Breast cancer is a malignancy that effects women across the world and is most prevalent among various types of cancers. Patents are jurisdiction specific exclusive rights that are...more
Richard Hsu, a technology transactions and intellectual property partner in the Mergers & Acquisitions Group at Shearman & Sterling, illustrates a creative structure for financing drug development....more
Earlier this month, the Generic Pharmaceutical Association (GPhA) held a press conference to announce the release of a study of the effects of reverse settlement payment agreements in ANDA litigation. ...more
This article analyzes the US Supreme Court's recent antitrust decision in FTC v. Actavis, which held that that courts should apply the rule of reason in analyzing reverse-payment settlements.
Welcome to the summer issue of News and Insights. In this issue, I’m proud to highlight Becca McKnight, who was recently selected by The Food and Drug Law Institute (FDLI) to serve on its Medical Devices Committee. Becca...more
In 2007, Dey L.P., Dey Inc., and their parent company Mylan, Inc. (collectively, "Dey") sued Sunovion Pharmaceutical, Inc. ("Sunovion"; formerly known as Sepracor, Inc.) for infringement of five of Dey's patents....more
Developers seeking to innovate using wireless terminals, information networks and devices, as well as users seeking to exploit new innovations, generate proprietary rights that may need to be perfected, and which might be...more